Top Markets
Coin of the day
Amniotics AB (publ) Amniotics AB (publ)

Amniotics AB (publ)

AMNI
Rang in aandelen #37511
Amniotics AB (publ) specializes in the creation, manufacturing, and... Amniotics AB (publ) specializes in the creation, manufacturing, and commercialization of stem cell-based therapies, utilizing mesenchymal stem cells to address critical, life-threatening illnesses. The company's primary therapeutic candidate, PulmoStem, is designed for the treatment of inflammatory and fibrotic conditions affecting the lungs. Furthermore, Amniotics is advancing other promising treatments such as CogniStem for neurological disorders, NephroStem for kidney-specific ailments, and CutiStem for various dermatological issues. Beyond its own pipeline, the firm provides contract development and manufacturing services for advanced therapy medicinal products to pharmaceutical companies, universities, and hospitals. Established in 2015, Amniotics AB is headquartered in Lund, Sweden.
Aandeelprijs
$0.00060315
Laatst gesynchroniseerd: 2024-09-27
Marktkapitalisatie
$1.65M
Verandering (1 dag)
19.64%
Verandering (1 jaar)
0.00%
Land
SE
Handel Amniotics AB (publ) (AMNI)

Categorie

Dividendrendementgeschiedenis voor Amniotics AB (publ) (AMNI)
Het dividendrendement (TTM) van Amniotics AB (publ) (aandelsymbool: AMNI) per 2022-12-31 is: 0.00%
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van Amniotics AB (publ) (AMNI) van 2018 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
2026 (TTM) 0.00% 0.00%
2023 0.00% 0.00%
2022 0.00% 0.00%
2021 0.00% 0.00%
2020 0.00% 0.00%
2019 0.00% 0.00%
2018 0.00% 0.00%
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten